Researchers in the lab of Whitehead Institute Founding Member Robert Weinberg have determined how mesenchymal cancer cells may resist treatment, work that may allow them to make once-resistant tumors respond to certain cancer therapies.
Tobiloba Oni—a cell biologist whose graduate research at Cold Spring Harbor Laboratory helped open new paths for understanding, detecting, and potential treating pancreatic cancer—has been appointed as a Whitehead Fellow.
Whitehead Institute’s core facilities set it apart. The cores, staffed by experts and providing state-of-the-art instrumentation and tools, allow our scientists to pursue more ambitious investigations.
Researchers in Richard Young’s lab at Whitehead Institute and collaborators have discovered how certain cancer therapeutics concentrate within cells -- a finding that could change the way scientists think about drug design.